Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/65488
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Nilotinib does not significantly reduce imatinib OCT-1 activity in either cell lines or primary CML cells
Author: Eadie, L.
Hughes, T.
White, D.
Citation: Leukemia, 2010; 24(4):855-857
Publisher: Nature Publishing Group
Issue Date: 2010
ISSN: 0887-6924
1476-5551
Statement of
Responsibility: 
L. Eadie, T. P. Hughes and D. L. White
Keywords: Tumor Cells, Cultured
Humans
Benzamides
Tetraethylammonium
Piperazines
Pyrimidines
Prazosin
Adrenergic alpha-Antagonists
Protein Kinase Inhibitors
Drug Therapy, Combination
Octamer Transcription Factor-1
Protein-Tyrosine Kinases
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Imatinib Mesylate
Rights: © 2011 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.
DOI: 10.1038/leu.2010.7
Published version: http://dx.doi.org/10.1038/leu.2010.7
Appears in Collections:Agriculture, Food and Wine publications
Aurora harvest

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.